台股 » 個股 » 厚生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

厚生

(2107)
可現股當沖
  • 股價
    27.00
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    273
  • 產業
    上市 橡膠類股
  • 202人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
厚生 (2107)籌碼相關-兆豐-復興 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

兆豐-復興 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/1600.00026.7526.7506040.00%
2024/04/2500.000.226.0025.95-0.2404-0.05%
2024/04/2300.000.825.6025.75-0.8392-0.20%
2024/04/1100.000.125.3025.05-0.1294-0.03%
2024/04/0300.000.324.7524.75-0.3283-0.11%
2024/03/280.324.2000.0024.250.32980.10%
2024/03/20024.2000.0024.0502790.00%
2023/11/160.423.4000.0023.450.43170.13%
2023/09/180.123.0000.0023.000.14990.02%
2023/09/06121.8500.0021.8514980.20%
2023/04/1300.00521.9021.95-5292-1.71%
2023/03/2000.00521.7421.80-5246-2.03%
2023/02/0300.00122.2022.25-1225-0.44%
2022/09/121021.5500.0021.45102713.68%
2022/05/30121.6500.0021.8512800.36%
2022/03/1800.007221.8922.05-72299-24.01%
2022/01/1300.00822.8022.70-8324-2.46%
2021/12/1600.00022.4522.4504110.00%
2021/10/2200.00222.9522.90-2531-0.38%
2021/10/20223.0000.0022.9525370.37%
2021/07/2600.00124.1524.10-11,187-0.08%
2021/07/122124.5000.0024.55211,9211.09%
2021/07/091025.4000.0025.45102,0170.50%
2021/06/21124.3000.0024.3012,3350.04%
2021/06/16124.5000.0024.5512,5540.04%
2021/05/0700.00026.0026.1002,6730.00%
2021/05/0600.000.126.2026.25-0.12,660-0.01%
2021/05/0500.000.426.4026.20-0.42,644-0.01%
2021/05/032027.1000.0026.75202,5890.77%
2021/04/2800.002028.2528.15-202,538-0.79%
2021/04/2000.005.226.7027.35-5.22,190-0.24%
2021/04/1500.00926.0626.45-91,970-0.46%
2021/04/13525.5500.0025.2051,8670.27%
2021/04/0900.00124.9525.15-11,727-0.06%
2021/03/2300.000.324.3524.20-0.31,682-0.02%
2021/03/2200.00224.7024.45-21,674-0.12%
2021/03/19625.3200.0025.8061,5590.38%
2021/03/1500.002524.4524.45-251,521-1.64%
2021/03/10124.452524.4024.45-241,694-1.42%
2021/03/09525.2000.0024.9051,6950.29%
2021/03/085025.25125.0524.85491,6772.92%
2021/03/05124.200.624.8525.000.41,5940.03%
2021/03/0200.00123.8523.90-11,648-0.06%
2021/02/18123.4500.0023.4512,2150.05%
2021/01/2800.00322.6022.60-32,434-0.12%
2021/01/2600.00322.9022.85-32,434-0.12%
2021/01/065024.50424.0524.10462,2892.01%
2020/12/3000.00024.9524.8002,2340.00%
2020/12/25425.2300.0024.9042,2060.18%
2020/12/0900.001024.2324.30-102,172-0.46%
2020/11/30225.4000.0025.0022,2660.09%
2020/11/241025.0500.0025.20102,4200.41%
2020/11/2300.001524.6725.80-152,349-0.64%
2020/11/2000.001523.4223.95-152,162-0.69%
2020/11/19322.8500.0022.9032,0960.14%
2020/11/18422.90423.0523.0002,1770.00%
2020/11/17222.7500.0022.8522,1460.09%
2020/11/161522.1500.0021.95152,0830.72%
2020/11/131022.00121.8022.0092,0360.44%
2020/11/11222.20221.8521.7502,0540.00%
2020/11/1000.00120.9021.00-11,997-0.05%
2020/11/09121.1500.0021.1012,0020.05%
2020/09/21421.6800.0021.4041,9450.21%
2020/09/1800.00221.1020.95-21,919-0.10%
2020/09/16220.8500.0020.8021,9230.10%
2020/09/0900.006522.0522.30-651,780-3.65%
2020/09/084221.2200.0020.95421,6632.52%
2020/09/072221.601222.0021.75101,6260.61%
2020/09/02320.7500.0020.9031,5280.20%
2020/09/011020.9500.0021.00101,5130.66%
2020/08/241519.051719.2619.40-21,151-0.17%
2020/08/21218.6000.0018.6021,0550.19%
2020/07/0900.00118.1518.20-11,032-0.10%
2020/07/02118.3500.0018.4511,0200.10%
2020/04/2100.00116.9516.95-1911-0.11%
2020/04/20117.5000.0017.5019020.11%
2020/02/0400.00618.4118.45-6665-0.90%
2020/01/3100.00218.9519.00-2644-0.31%
2020/01/20819.7500.0019.7086181.29%
2019/12/2400.00118.8018.70-1649-0.15%
2019/12/16118.7500.0018.8516520.15%
2019/10/2200.00619.0418.95-6587-1.02%
2019/10/21619.0400.0019.0065901.02%
2019/10/14118.65118.3518.3505510.00%
2019/08/2300.00218.8518.90-2903-0.22%
2019/08/19218.0500.0018.1029190.22%
2019/06/1200.00318.4518.15-3663-0.45%
2019/06/1100.00318.5518.55-3643-0.47%
2019/06/10618.0500.0018.4065911.01%
2019/01/0900.00115.6015.65-1390-0.26%
2018/12/2800.00415.5015.60-4429-0.93%
2018/12/27515.5000.0015.5554391.14%
2018/12/2400.00515.3515.45-5451-1.11%
2018/12/2100.00115.3015.45-1450-0.22%
2018/12/18615.3500.0015.4064521.33%
2018/06/2800.00214.5014.40-2317-0.63%
向榮生技海外布局傳捷報 通過日本厚生省細胞培養加工設施查核Anue鉅亨-2024/05/15
昱厚生技盼加速鼻噴劑型應用 推進三產品臨床試驗Anue鉅亨-2023/06/30
厚生 相關文章
厚生 相關影音